Journal rankings · indicator year 2014
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2014
Pharmacology journal rankings 2014
17 ranked journals · Subfield in Pharmacology, Toxicology and Pharmaceutics
Pharmacology has 17 ranked journals in 2014. The median OJR fell 0.28 on 2013 to 1.05, above the world average of 1.00; Q1 starts at OJR 1.56. The top three are The Pharmacogenomics Journal, Current Drug Metabolism, and Drug Metabolism and Disposition.
Ranks and citation indicators: 2014. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2011–2013, the window the 2014 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Pharmacology, Toxicology and Pharmaceutics (4)
17 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2013. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2011–2013, the window the 2014 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2011–2013 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2005 to 2014. | Compare |
|---|---|---|---|---|---|---|---|
1The Pharmacogenomics JournalSpringer Nature · United Kingdom | 1.91Q1 | 4.89 0.50 up from 2013 | 163 | 40% | $4,890 | ||
2Current Drug MetabolismBentham Science Publishers · Netherlands | 1.68Q1 | 3.11 0.38 down from 2013 | 340 | 12% | — | ||
3Drug Metabolism and DispositionAmerican Society for Pharmacology and Experimental Therapeutics · United States | 1.64Q1 | 3.67 0.31 down from 2013 | 797 | 27% | $3,500 | ||
4Expert Opinion on Drug Metabolism & ToxicologyTaylor & Francis · United Kingdom | 1.60Q1 | 3.20 0.24 down from 2013 | 388 | 15% | — | ||
5Pharmacogenetics and GenomicsLippincott Williams & Wilkins · United Kingdom | 1.56Q1 | 3.47 0.22 down from 2013 | 295 | 38% | — | ||
6Biopharmaceutics & Drug DispositionWiley · United Kingdom | 1.40Q2 | 2.82 0.12 down from 2013 | 157 | 10% | $3,800 | ||
7Drug Metabolism and PharmacokineticsElsevier BV · Japan | 1.16Q2 | 2.17 0.75 down from 2013 | 249 | 5% | $3,580 | ||
8PharmacogenomicsFuture Medicine · United Kingdom | 1.15Q2 | 2.50 0.43 down from 2013 | 602 | 26% | — | ||
9XenobioticaTaylor & Francis · United Kingdom | 1.05Q2 | 2.10 0.13 down from 2013 | 376 | 7% | — | ||
10Drug metabolism and drug interactionsDe Gruyter · Germany | 0.97Q3 | 1.63 0.05 down from 2013 | 95 | 20% | — | ||
11Clinical and Translational ScienceOAWiley · United Kingdom | 0.91Q3 | 1.49 1.04 down from 2013 | 237 | 96% | $3,630 | ||
12European Journal of Drug Metabolism and PharmacokineticsAdis, Springer Healthcare · France | 0.66Q3 | 1.02 0.64 down from 2013 | 140 | 15% | $2,690 | ||
13Innovative Romanian Food BiotechnologyOARomania | 0.59Q3 | 0.81 0.86 down from 2013 | 30 | 100% | — | ||
14Drug Metabolism LettersBentham Science Publishers · Netherlands | 0.51Q4 | 0.85 0.28 down from 2013 | 97 | 6% | — | ||
15Pharmacology & PharmacyOAScientific Research Publishing · United States | 0.31Q4 | 0.62 0.10 up from 2013 | 225 | 100% | — | ||
16International Research Journal of PharmacyMoksha Publishing House · India | 0.21Q4 | 0.35no 2013 value | 347 | 86% | — | — | |
17YAKUGAKU ZASSHIOAPharmaceutical Society of Japan · Japan | 0.18Q4 | 0.32 0.05 down from 2013 | 614 | 100% | — |
Subfields of Pharmacology, Toxicology and Pharmaceutics, with Pharmacology highlighted.
Journals
Citations made in 2014. Corpus-wide, 77.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
8 additional Pharmacology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2011–2013, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2014. Publication window: 2011–2013. How these summaries are calculated
- Ranked journals
- 17
- Window papers (baseline)
- 35,457 +13.6% from indicator year 2011
- Median OJR
- 1.054 -17.6% from indicator year 2011
- Rising journals (2025)
- 0
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2011–2013 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 8 | 9 | 11 | 12 | 12 | 12 | 14 | 14 | 14 | 15 | 14 | 14 | 15 | 15 | 17 | 18 | 20 | 18 | 19 | 19 | 18 | 19 | 21 | 20 | 20 | 16 | |
| Window papers (baseline) | 9,721 | 10,811 | 12,118 | 13,777 | 15,001 | 16,671 | 18,550 | 20,892 | 23,456 | 26,004 | 28,909 | 31,210 | 33,581 | 34,528 | 35,457 | 34,548 | 32,736 | 29,638 | 27,101 | 25,829 | 26,009 | 27,551 | 28,758 | 29,180 | 28,580 | 29,439 | |
| Median OJR | 0.36 | 0.38 | 1.08 | 1.11 | 0.94 | 0.809 | 1.052 | 1.43 | 1.33 | 1.54 | 1.42 | 1.28 | 1.19 | 1.34 | 1.054 | 0.90 | 0.91 | 0.84 | 0.810 | 0.72 | 0.77 | 0.61 | 0.60 | 0.59 | 0.58 | 0.68 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.